Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA)

Q: What does CUSIP 74365U107 represent in this 13F holders report?

CUSIP 74365U107 is the security identifier for TARA - Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held TARA - Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q4 2021?

36 institutional investors reported TARA - Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q4 2021. Use the holders table for investor-level position and value details.

CUSIP: 74365U107

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 54,102,569
Total 13F shares: 6,872,165
Share change: +569,362
Total reported value: $46,492,675
Price per share: $6.75
Number of holders: 36
Value change: +$3,840,591
Number of buys: 19
Number of sells: 13

Quarterly Holders Quick Answers

What is CUSIP 74365U107?
CUSIP 74365U107 identifies TARA - Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 74365U107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TARA - Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Opaleye Management Inc.	13F	Company	4.7%	2,558,472	$17,705,000	—	30 Sep 2021	13F
Ikarian Capital, LLC	13F	Company	0.89%	479,995	$3,321,000	—	30 Sep 2021	13F
ORBIMED ADVISORS LLC	13F	Company	0.83%	450,000	$3,114,000	—	30 Sep 2021	13F
VANGUARD GROUP INC	13F	Company	0.81%	435,813	$3,015,000	—	30 Sep 2021	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.78%	421,641	$2,918,000	—	30 Sep 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.64%	346,431	$2,398,000	—	30 Sep 2021	13F
Boxer Capital, LLC	13F	Company	0.39%	209,227	$1,448,000	—	30 Sep 2021	13F
BAKER BROS. ADVISORS LP	13F	Company	0.37%	199,671	$1,382,000	—	30 Sep 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.31%	168,818	$1,168,000	—	30 Sep 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.29%	155,973	$1,079,000	—	30 Sep 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.24%	130,935	$906,000	—	30 Sep 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.21%	115,900	$802,000	—	30 Sep 2021	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.21%	112,500	$779,000	—	30 Sep 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.19%	104,918	$726,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.15%	79,017	$546,000	—	30 Sep 2021	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.09%	47,423	$328,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	0.08%	44,036	$306,000	—	30 Sep 2021	13F
David M. Knott	13F	Individual	0.07%	36,479	$252,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	0.05%	26,569	$184,000	—	30 Sep 2021	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.04%	23,955	$166,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	0.04%	22,800	$158,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	0.04%	22,279	$154,000	—	30 Sep 2021	13F
Bank of New York Mellon Corp	13F	Company	0.03%	17,907	$124,000	—	30 Sep 2021	13F
Virtu Financial LLC	13F	Company	0.03%	17,130	$119,000	—	30 Sep 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.03%	15,893	$110,000	—	30 Sep 2021	13F
MARSHALL WACE, LLP	13F	Company	0.03%	15,190	$105,000	—	30 Sep 2021	13F
Jump Financial, LLC	13F	Company	0.03%	14,500	$100,000	—	30 Sep 2021	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0.02%	13,155	$91,000	—	30 Sep 2021	13F
Trexquant Investment LP	13F	Company	0.02%	12,454	$86,000	—	30 Sep 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	8,040	$56,000	—	30 Sep 2021	13F
Martin Sebastian Olivo	3/4/5	Chief Medical Officer	— class O/S missing	14,344	$27,397	—	10 Jun 2021	3/4/5
OSAIC HOLDINGS, INC.	13F	Company	0%	2,600	$18,000	—	30 Sep 2021	13F
SIMPLEX TRADING, LLC	13F	Company	0%	581	$5,000	—	30 Sep 2021	13F
ROYAL BANK OF CANADA	13F	Company	0%	600	$4,000	—	30 Sep 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	500	$3,000	—	30 Sep 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	459	$3,000	—	30 Sep 2021	13F
American Portfolios Advisors	13F	Company	0%	100	$692	—	30 Sep 2021	13F

Institutional Holders of Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA) as of Q4 2021

As of 31 Dec 2021, Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,872,165 shares. The largest 10 holders included Opaleye Management Inc., ORBIMED ADVISORS LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, PERCEPTIVE ADVISORS LLC, Ikarian Capital, LLC, DLD Asset Management, LP, BOXER CAPITAL, LLC, BAKER BROS. ADVISORS LP, and GOLDMAN SACHS GROUP INC. This page lists 36 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

Q4 2021 holders

Holder diff

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.